SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-091856
Filing Date
2022-03-31
Accepted
2022-03-31 16:27:43
Documents
14
Period of Report
2022-03-31
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d342643d8k.htm   iXBRL 8-K 23973
2 EX-99.1 d342643dex991.htm EX-99.1 69143
6 GRAPHIC g342643g01o74.jpg GRAPHIC 3018
  Complete submission text file 0001193125-22-091856.txt   228539

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA iobt-20220331.xsd EX-101.SCH 2863
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE iobt-20220331_lab.xml EX-101.LAB 17911
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE iobt-20220331_pre.xml EX-101.PRE 11239
8 EXTRACTED XBRL INSTANCE DOCUMENT d342643d8k_htm.xml XML 3330
Mailing Address OLE MAALOES VEH 3 COPENHAGEN G7 2200
Business Address OLE MAALOES VEH 3 COPENHAGEN G7 2200 4570702980
IO Biotech, Inc. (Filer) CIK: 0001865494 (see all company filings)

IRS No.: 870909276 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41008 | Film No.: 22792976
SIC: 2834 Pharmaceutical Preparations